Description
Radotinib (IY-5511), and sometimes referred to by its investigational name IY5511, is a drug for the treatment of different types of Y, most notably Philadelphia chromosome-positive (Ph+) chronic myeloid leukemia (CML) with resistance or intolerance of other tyrosine kinase Bcr-Abl inhibitors
Molecular Formula
C27H21F3N8O
Smiles
CC1CN(CN1)-C1CC(NC(=O)C2CCC(C)C(NC3NCCC(N3)-C3CNCCN3)C2)CC(C1)C(F)(F)F
Storage
Powder: -20℃ for 3 years. In solvent: -80℃ for 1 year.
Solubility Information
Ethanol: < 1 mg/mL (insoluble or slightly soluble)DMSO: 5.3 mg/mL (10 mM)
Relative Density
1.40 (Predicted)